Balancing the risks and rewards of live biotherapeutics.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. The role of gut microbiota-mitochondria crosstalk in neurodegeneration: Underlying mechanisms and potential therapies.Neural regeneration research · 2026
   Article
2. Injectable living hydrogel as engineered biotherapeutic to promote tooth-extraction wound healing and alveolar bone regeneration.Bioactive materials · 2026
   Article
3. The pasteurized Weissella cibaria alleviates sepsis-induced acute lung injury by modulation of intestinal mucus barrier and gut microbiota.Journal of translational medicine · 2025
   Article
4. Genetic evidence of bidirectional mendelian randomization study on the causality between gut microbiome and respiratory diseases contributes to gut-lung axis.Scientific reports · 2024
   Article
5. The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: A review.Food science & nutrition · 2024
   Review
6. Scarring the early-life microbiome: its potential life-long effects on human health and diseases.BMB reports · 2023
   Review
7. Early gut microbiota intervention in premature infants: Application perspectives.Journal of advanced research · 2023
   Review
8. Optimized Antimicrobial Peptide Jelleine-I Derivative Br-J-I Inhibits Fusobacterium Nucleatum to Suppress Colorectal Cancer Progression.International journal of molecular sciences · 2023
   Article
9. Online information in Spanish on probiotics, yoghurt, kefir, kombucha, fibre and prebiotics: an analysis of the quality of information and the certainty of the evidence supporting health claims.BMJ open · 2022
   Article
10. Bornlisy Attenuates Colitis-Associated Colorectal CancerFrontiers in nutrition · 2021
    Article
11. Human Microbiome and Its Medical Applications.Frontiers in molecular biosciences · 2021
    Review
12. Emerging issues in probiotic safety: 2023 perspectives.Gut microbes
    Article

Corrections and comments

• Comment on
  Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients.2019
• Comment on
  Drug-Resistant2019

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as